Chiron Announces New North American Distribution Agreements
Chiron AS (Trondheim, Norway) has announced new North American distribution partnerships with Ibis Scientific, LLC (Las Vegas, USA) and Chromatographic Specialties Inc. (Ontario, Canada).
“Access to high quality and innovative analytical standards is essential to research,” said Jon Johansen, Managing Director at Chiron. “These new distribution agreements will help to ensure our products are more easily available to customers across North America, benefitting the wider scientific community.”
Ibis Scientific is a leading regional provider of analytical laboratory products, certified reference standards, and consumables for gas and liquid chromatography (GC/LC) and inductively coupled plasma–mass spectrometry (ICP/ICP-MS) workflows.
“Our nationwide shipping and warehouse supply locations will provide a host of benefits for Chiron’s customers. We firmly believe that this exciting new agreement will be of huge benefit to everyone involved,” said Justin Spencer, President of Ibis Scientific.
Chromatographic Specialties has over 55 years of expertise in GC and LC, supplying instrumentation, chemicals, and sample preparation consumables to the Canadian scientific community.
“We’re delighted to be a part of the Chiron distributor family. We are fully committed to providing our customers with high quality products, backed by expert technical support. Chiron’s range of products is an excellent fit for us,” said Ken Jordan, Sales and Marketing Manager at Chromatographic Specialties.
These newest partners will be joining Chiron’s existing representatives across North America–Caledon, Sapphire NA, and Design Scientific–to further strengthen the company’s product supply network.
For more information, please visit: www.chiron.no
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
